Evidence map›Paper›PMID 39545408›Full record

ArticleThe Journal of clinical investigation2024

Xylazine induces dopamine release and augments the effects of fentanyl.

Joseph R Trinko, Ethan Foscue, Edward M Kong, Aakash Basu, Anouk M Corstens, Summer L Thompson, Alfred P Kaye, Jane R Taylor, Ralph J DiLeone

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frozen in Addiction: A New Wave of Drug-Induced Movement Disorders?Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joseph R TrinkoDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Ethan FoscueDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Edward M KongDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Aakash BasuDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Anouk M CorstensDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Summer L ThompsonDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Alfred P KayeDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Jane R TaylorDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Ralph J DiLeoneDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Funding

NEUROBIOLOGY OF CORTICAL SYSTEMST32NS007224 · NINDS · YALE UNIVERSITY · PI CARDIN, JESSICA A · 1985 to 2025
$4.6M
NINDS NIH HHS T32 NS007224
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AddictionNeuroscience

Identifiers

PMID39545408
PMCPMC11563672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.